Q&A

Guiding Customers Through Drug Development Challenges With Intelligent Collaboration

A Q&A with JoyL Silva

Decreasing Timelines In Infectious Diseases Drug Development

Taking on the role as General Manager of Pfizer CentreOne, JoyL Silva leads Pfizer’s embedded contract development and manufacturing organization (CDMO).  JoyL brings a wide range of commercial, strategy, and business leadership experience spanning her 20-year career at Pfizer. Following is a recent discussion with JoyL around what it’s like to lead an embedded CDMO within one of the largest pharmaceutical companies and where the Pfizer CentreOne business is headed.

You’ve held some exciting leadership roles in Pfizer and are now managing the company’s prominent CDMO business. What have you learned from the transition?

When transitioning to Pfizer CentreOne, I hit the road … a lot. I have spent time with our manufacturing sites, our scientists, quality, commercial / marketing teams and especially with our customers. This time spent has given me confidence in who we are, the intelligent collaborators we’ve become and why we are uniquely positioned in the market to offer a full range of products. That includes our APIs and intermediates business as well as strategic contract drug development and manufacturing service offerings to customers.

VIEW THE Q&A!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: